In the last 12 months, insiders at MACROGENICS INC ($MGNX) filed 347 transactions with the SEC: 7 open-market purchases totaling $5,274,115 and 19 sales totaling $5,028,714. Net insider sentiment: net buying.
MACROGENICS INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- BIOTECH TARGET N V (TenPercentOwner) — 4 transactions totaling $5,049,950
- Peters Jeffrey Stuart (Senior VP and General Counsel) — 42 transactions totaling $4,350,249
- Risser Eric Blasius (Chief Operating Officer) — 19 transactions totaling $1,095,723
- Bonvini Ezio (Sr VP, Research & CSO) — 35 transactions totaling $930,871
- Karrels James (SVP, CFO and Secretary) — 16 transactions totaling $732,551
View all SEC Filings for MACROGENICS INC (MGNX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | Karrels James | SVP and CFO | M | Restricted Stock Unit | 14999 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.02% |
| Feb. 12, 2026 | Karrels James | SVP and CFO | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 63,283,624 | 9999.99% | 0.24% |
| Feb. 12, 2026 | Karrels James | SVP and CFO | A | Restricted Stock Unit | 25000 | $0.00 | 25,000.0000 | 63,283,624 | 9999.99% | 0.04% |
| Feb. 15, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | M | Common Stock | 13332 | $0.00 | 36,252.0000 | 63,283,624 | 58.17% | 0.02% |
| Feb. 15, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | F | Common Stock | 5147 | $1.71 | 31,105.0000 | 63,283,624 | 14.20% | 0.01% |
| Feb. 15, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | M | Restricted Stock Unit | 13332 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.02% |
| Feb. 12, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 63,283,624 | 9999.99% | 0.24% |
| Feb. 12, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | A | Restricted Stock Unit | 25000 | $0.00 | 25,000.0000 | 63,283,624 | 9999.99% | 0.04% |
| Feb. 15, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 13332 | $0.00 | 44,063.0000 | 63,283,624 | 43.38% | 0.02% |
| Feb. 15, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | F | Common Stock | 5520 | $1.71 | 38,543.0000 | 63,283,624 | 12.53% | 0.01% |
| Feb. 15, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | M | Restricted Stock Unit | 13332 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.02% |
| Feb. 12, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | A | Restricted Stock Unit | 25000 | $0.00 | 25,000.0000 | 63,283,624 | 9999.99% | 0.04% |
| Feb. 12, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 63,283,624 | 9999.99% | 0.24% |
| Feb. 15, 2026 | Risser Eric Blasius | President and CEO | M | Common Stock | 16665 | $0.00 | 83,602.0000 | 63,283,624 | 24.90% | 0.03% |
| Feb. 15, 2026 | Risser Eric Blasius | President and CEO | F | Common Stock | 6433 | $1.71 | 77,169.0000 | 63,283,624 | 7.69% | 0.01% |
| Feb. 15, 2026 | Risser Eric Blasius | President and CEO | M | Restricted Stock Unit | 16665 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.03% |
| Feb. 12, 2026 | Risser Eric Blasius | President and CEO | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 63,283,624 | 9999.99% | 0.16% |
| Feb. 12, 2026 | Risser Eric Blasius | President and CEO | A | Employee Stock Option (right to buy) | 595000 | $0.00 | 595,000.0000 | 63,283,624 | 9999.99% | 0.94% |
| Feb. 15, 2026 | Koenig Scott | Director | M | Common Stock | 21165 | $0.00 | 867,240.0000 | 63,283,624 | 2.50% | 0.03% |
| Feb. 15, 2026 | Koenig Scott | Director | M | Restricted Stock Unit | 21165 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.03% |
| Feb. 15, 2026 | Smith Beth Ann | VP, Controller & Treasurer | M | Common Stock | 1095 | $0.00 | 13,204.0000 | 63,283,624 | 9.04% | 0.00% |
| Feb. 15, 2026 | Smith Beth Ann | VP, Controller & Treasurer | F | Common Stock | 423 | $1.71 | 12,781.0000 | 63,283,624 | 3.20% | 0.00% |
| Feb. 15, 2026 | Smith Beth Ann | VP, Controller & Treasurer | M | Restricted Stock Unit | 1095 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.00% |
| Feb. 12, 2026 | Smith Beth Ann | VP, Controller & Treasurer | A | Restricted Stock Unit | 15625 | $0.00 | 15,625.0000 | 63,283,624 | 9999.99% | 0.02% |
| Feb. 12, 2026 | Smith Beth Ann | VP, Controller & Treasurer | A | Employee Stock Option (right to buy) | 93750 | $0.00 | 93,750.0000 | 63,283,624 | 9999.99% | 0.15% |
| Feb. 15, 2026 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 16665 | $0.00 | 152,232.0000 | 63,283,624 | 12.29% | 0.03% |
| Feb. 15, 2026 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 6433 | $1.71 | 145,799.0000 | 63,283,624 | 4.23% | 0.01% |
| Feb. 15, 2026 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 16665 | $0.00 | 0.0000 | 63,283,624 | 100.00% | 0.03% |
| Feb. 12, 2026 | Bonvini Ezio | Sr VP, Research & CSO | A | Restricted Stock Unit | 31250 | $0.00 | 31,250.0000 | 63,283,624 | 9999.99% | 0.05% |
| Feb. 12, 2026 | Bonvini Ezio | Sr VP, Research & CSO | A | Employee Stock Option (right to buy) | 187500 | $0.00 | 187,500.0000 | 63,283,624 | 9999.99% | 0.30% |
| Feb. 15, 2026 | Karrels James | SVP and CFO | M | Common Stock | 14999 | $0.00 | 211,827.0000 | 63,283,624 | 7.62% | 0.02% |
| Feb. 15, 2026 | Karrels James | SVP and CFO | F | Common Stock | 5790 | $1.71 | 206,037.0000 | 63,283,624 | 2.73% | 0.01% |
| Feb. 8, 2026 | Koenig Scott | Director | M | Restricted Stock Unit | 15831 | $0.00 | 15,832.0000 | 63,283,624 | 50.00% | 0.03% |
| Feb. 7, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 6001 | $0.00 | 27,403.0000 | 63,283,624 | 28.04% | 0.01% |
| Feb. 7, 2026 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 2703 | $1.81 | 128,712.0000 | 63,283,624 | 2.06% | 0.00% |
| Feb. 8, 2026 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 11166 | $0.00 | 139,878.0000 | 63,283,624 | 8.68% | 0.02% |
| Feb. 8, 2026 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 4311 | $1.81 | 135,567.0000 | 63,283,624 | 3.08% | 0.01% |
| Feb. 7, 2026 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 7001 | $0.00 | 13,999.0000 | 63,283,624 | 33.34% | 0.01% |
| Feb. 8, 2026 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 11166 | $0.00 | 11,166.0000 | 63,283,624 | 50.00% | 0.02% |
| Feb. 8, 2026 | Koenig Scott | Director | M | Common Stock | 15831 | $0.00 | 846,075.0000 | 63,283,624 | 1.91% | 0.03% |
| Feb. 7, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | F | Common Stock | 2485 | $1.81 | 24,918.0000 | 63,283,624 | 9.07% | 0.00% |
| Feb. 7, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | M | Restricted Stock Unit | 6001 | $0.00 | 11,999.0000 | 63,283,624 | 33.34% | 0.01% |
| Feb. 8, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | F | Common Stock | 3186 | $1.81 | 30,731.0000 | 63,283,624 | 9.39% | 0.01% |
| Feb. 8, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 8999 | $0.00 | 33,917.0000 | 63,283,624 | 36.11% | 0.01% |
| Feb. 8, 2026 | Risser Eric Blasius | President and CEO | F | Common Stock | 4311 | $1.81 | 66,937.0000 | 63,283,624 | 6.05% | 0.01% |
| Feb. 8, 2026 | Risser Eric Blasius | President and CEO | M | Common Stock | 11166 | $0.00 | 71,248.0000 | 63,283,624 | 18.58% | 0.02% |
| Feb. 7, 2026 | Risser Eric Blasius | President and CEO | F | Common Stock | 2575 | $1.81 | 60,082.0000 | 63,283,624 | 4.11% | 0.00% |
| Feb. 7, 2026 | Risser Eric Blasius | President and CEO | M | Common Stock | 6668 | $0.00 | 62,657.0000 | 63,283,624 | 11.91% | 0.01% |
| Feb. 8, 2026 | Smith Beth Ann | VP, Controller & Treasurer | M | Restricted Stock Unit | 1583 | $0.00 | 1,584.0000 | 63,283,624 | 49.98% | 0.00% |
| Feb. 7, 2026 | Smith Beth Ann | VP, Controller & Treasurer | M | Restricted Stock Unit | 2617 | $0.00 | 5,233.0000 | 63,283,624 | 33.34% | 0.00% |
| Feb. 8, 2026 | Smith Beth Ann | VP, Controller & Treasurer | F | Common Stock | 612 | $1.81 | 12,109.0000 | 63,283,624 | 4.81% | 0.00% |
| Feb. 8, 2026 | Smith Beth Ann | VP, Controller & Treasurer | M | Common Stock | 1583 | $0.00 | 12,721.0000 | 63,283,624 | 14.21% | 0.00% |
| Feb. 7, 2026 | Smith Beth Ann | VP, Controller & Treasurer | F | Common Stock | 1011 | $1.81 | 11,138.0000 | 63,283,624 | 8.32% | 0.00% |
| Feb. 7, 2026 | Risser Eric Blasius | President and CEO | M | Restricted Stock Unit | 6668 | $0.00 | 13,332.0000 | 63,283,624 | 33.34% | 0.01% |
| Feb. 7, 2026 | Smith Beth Ann | VP, Controller & Treasurer | M | Common Stock | 2617 | $0.00 | 12,149.0000 | 63,283,624 | 27.45% | 0.00% |
| Feb. 8, 2026 | Spitznagel Thomas | Sr VP, Technical Ops | M | Restricted Stock Unit | 8999 | $0.00 | 9,000.0000 | 63,283,624 | 50.00% | 0.01% |
| Feb. 8, 2026 | Risser Eric Blasius | President and CEO | M | Restricted Stock Unit | 11166 | $0.00 | 11,166.0000 | 63,283,624 | 50.00% | 0.02% |
| Feb. 7, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | M | Common Stock | 6001 | $0.00 | 19,712.0000 | 63,283,624 | 43.77% | 0.01% |
| Feb. 7, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | F | Common Stock | 2317 | $1.81 | 17,395.0000 | 63,283,624 | 11.75% | 0.00% |
| Feb. 8, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | M | Common Stock | 8999 | $0.00 | 26,394.0000 | 63,283,624 | 51.73% | 0.01% |
| Feb. 8, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | F | Common Stock | 3474 | $1.81 | 22,920.0000 | 63,283,624 | 13.16% | 0.01% |
| Feb. 7, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | M | Restricted Stock Unit | 6001 | $0.00 | 11,999.0000 | 63,283,624 | 33.34% | 0.01% |
| Feb. 8, 2026 | Peters Jeffrey Stuart | Senior VP, GC, and Secretary | M | Restricted Stock Unit | 8999 | $0.00 | 9,000.0000 | 63,283,624 | 50.00% | 0.01% |
| Feb. 7, 2026 | Karrels James | SVP and CFO | M | Common Stock | 6334 | $0.00 | 193,135.0000 | 63,283,624 | 3.39% | 0.01% |
| Feb. 7, 2026 | Karrels James | SVP and CFO | F | Common Stock | 2446 | $1.81 | 190,689.0000 | 63,283,624 | 1.27% | 0.00% |
| Feb. 8, 2026 | Karrels James | SVP and CFO | M | Common Stock | 9999 | $0.00 | 200,688.0000 | 63,283,624 | 5.24% | 0.02% |
| Feb. 8, 2026 | Karrels James | SVP and CFO | F | Common Stock | 3860 | $1.81 | 196,828.0000 | 63,283,624 | 1.92% | 0.01% |
| Feb. 7, 2026 | Karrels James | SVP and CFO | M | Restricted Stock Unit | 6334 | $0.00 | 12,666.0000 | 63,283,624 | 33.34% | 0.01% |
| Feb. 8, 2026 | Karrels James | SVP and CFO | M | Restricted Stock Unit | 9999 | $0.00 | 9,999.0000 | 63,283,624 | 50.00% | 0.02% |
| Feb. 7, 2026 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 7001 | $0.00 | 131,415.0000 | 63,283,624 | 5.63% | 0.01% |
| Dec. 8, 2025 | Smith Beth Ann | VP, Controller & Treasurer | A | Employee Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 63,283,624 | 9999.99% | 0.04% |
| Aug. 20, 2025 | HEIDEN WILLIAM K | Director | P | Common Stock | 49500 | $1.49 | 111,000.0000 | 62,621,185 | 80.49% | 0.08% |
| Aug. 19, 2025 | HEIDEN WILLIAM K | Director | P | Common Stock | 50500 | $1.52 | 61,500.0000 | 62,621,185 | 459.09% | 0.08% |
| Aug. 15, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Employee Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 62,621,185 | 9999.99% | 0.05% |
| Aug. 15, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | A | Employee Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 62,621,185 | 9999.99% | 0.05% |
| Aug. 13, 2025 | Koenig Scott | Director | M | Common Stock | 31664 | $0.00 | 830,244.0000 | 62,621,185 | 3.97% | 0.05% |
| Aug. 13, 2025 | Koenig Scott | Director | M | Restricted Stock Unit | 21165 | $0.00 | 21,165.0000 | 62,621,185 | 50.00% | 0.03% |
| Aug. 13, 2025 | Koenig Scott | Director | M | Restricted Stock Unit | 31664 | $0.00 | 31,663.0000 | 62,621,185 | 50.00% | 0.05% |
| Aug. 13, 2025 | Risser Eric Blasius | President and CEO | A | Employee Stock Option (right to buy) | 550000 | $0.00 | 550,000.0000 | 62,621,185 | 9999.99% | 0.88% |
| Aug. 13, 2025 | Koenig Scott | Director | M | Common Stock | 21165 | $0.00 | 798,580.0000 | 62,621,185 | 2.72% | 0.03% |
| May 20, 2025 | SIEGEL JAY PHILIP | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 20, 2025 | HEIDEN WILLIAM K | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | HEIDEN WILLIAM K | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | HEIDEN WILLIAM K | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | HEIDEN WILLIAM K | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 20, 2025 | STUMP DAVID C | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | STUMP DAVID C | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | STUMP DAVID C | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | STUMP DAVID C | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 20, 2025 | Ferrante Karen Jean | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | Ferrante Karen Jean | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | Ferrante Karen Jean | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | Ferrante Karen Jean | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 20, 2025 | Liu Margaret | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | Liu Margaret | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | Liu Margaret | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | Liu Margaret | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 20, 2025 | HURWITZ EDWARD | Director | M | Common Stock | 6500 | $0.00 | 44,074.0000 | 62,621,185 | 17.30% | 0.01% |
| May 20, 2025 | HURWITZ EDWARD | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | HURWITZ EDWARD | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | HURWITZ EDWARD | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 20, 2025 | Chhabra Meenu | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | Chhabra Meenu | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | Chhabra Meenu | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 21, 2025 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 49213 | $1.27 | 71,213.0000 | 62,621,185 | 223.70% | 0.08% |
| May 20, 2025 | SIEGEL JAY PHILIP | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 21, 2025 | SIEGEL JAY PHILIP | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | SIEGEL JAY PHILIP | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 20, 2025 | O'Brien Federica F. | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | O'Brien Federica F. | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | O'Brien Federica F. | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | O'Brien Federica F. | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 21, 2025 | O'Brien Federica F. | Director | A | Stock Option (right to buy) | 64961 | $1.27 | 86,961.0000 | 62,621,185 | 295.28% | 0.10% |
| May 20, 2025 | Jackson Scott Thomas | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 20, 2025 | Jackson Scott Thomas | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 21, 2025 | Jackson Scott Thomas | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 21, 2025 | Jackson Scott Thomas | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| Feb. 15, 2025 | Karrels James | SVP, CFO and Secretary | M | Common Stock | 14998 | $0.00 | 192,591.0000 | 62,621,185 | 8.45% | 0.02% |
| Feb. 15, 2025 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 16665 | $0.00 | 16,665.0000 | 62,621,185 | 50.00% | 0.03% |
| Feb. 15, 2025 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 16665 | $0.00 | 124,414.0000 | 62,621,185 | 15.47% | 0.03% |
| Feb. 15, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 13332 | $0.00 | 18,858.0000 | 62,621,185 | 241.26% | 0.02% |
| Feb. 15, 2025 | Koenig Scott | President and CEO | M | Restricted Stock Unit | 42329 | $0.00 | 42,330.0000 | 62,621,185 | 50.00% | 0.07% |
| Feb. 15, 2025 | Koenig Scott | President and CEO | M | Common Stock | 42329 | $0.00 | 777,415.0000 | 62,621,185 | 5.76% | 0.07% |
| Feb. 15, 2025 | Karrels James | SVP, CFO and Secretary | M | Restricted Stock Unit | 14998 | $0.00 | 14,999.0000 | 62,621,185 | 50.00% | 0.02% |
| Feb. 15, 2025 | Karrels James | SVP, CFO and Secretary | F | Common Stock | 5790 | $2.56 | 186,801.0000 | 62,621,185 | 3.01% | 0.01% |
| Feb. 15, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | F | Common Stock | 5147 | $2.56 | 13,711.0000 | 62,621,185 | 27.29% | 0.01% |
| Feb. 15, 2025 | Eck Stephen L. | Chief Medical Officer | M | Restricted Stock Unit | 16665 | $0.00 | 16,665.0000 | 62,621,185 | 50.00% | 0.03% |
| Feb. 15, 2025 | Eck Stephen L. | Chief Medical Officer | F | Common Stock | 4942 | $2.56 | 29,377.0000 | 62,621,185 | 14.40% | 0.01% |
| Feb. 15, 2025 | Eck Stephen L. | Chief Medical Officer | M | Common Stock | 16665 | $0.00 | 34,319.0000 | 62,621,185 | 94.40% | 0.03% |
| Feb. 15, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | M | Restricted Stock Unit | 13332 | $0.00 | 13,332.0000 | 62,621,185 | 50.00% | 0.02% |
| Feb. 15, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | F | Common Stock | 5520 | $2.56 | 21,402.0000 | 62,621,185 | 20.50% | 0.01% |
| Feb. 15, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 13332 | $0.00 | 26,922.0000 | 62,621,185 | 98.10% | 0.02% |
| Feb. 15, 2025 | Smith Beth Ann | VP, Controller & Treasurer | M | Restricted Stock Unit | 1095 | $0.00 | 1,095.0000 | 62,621,185 | 50.00% | 0.00% |
| Feb. 15, 2025 | Smith Beth Ann | VP, Controller & Treasurer | S | Common Stock | 423 | $2.56 | 9,532.0000 | 62,621,185 | 4.25% | 0.00% |
| Feb. 15, 2025 | Smith Beth Ann | VP, Controller & Treasurer | M | Common Stock | 1095 | $0.00 | 9,955.0000 | 62,621,185 | 12.36% | 0.00% |
| Feb. 15, 2025 | Risser Eric Blasius | Chief Operating Officer | M | Restricted Stock Unit | 16665 | $0.00 | 16,665.0000 | 62,621,185 | 50.00% | 0.03% |
| Feb. 15, 2025 | Risser Eric Blasius | Chief Operating Officer | F | Common Stock | 6433 | $2.56 | 55,989.0000 | 62,621,185 | 10.31% | 0.01% |
| Feb. 15, 2025 | Risser Eric Blasius | Chief Operating Officer | M | Common Stock | 16665 | $0.00 | 62,422.0000 | 62,621,185 | 36.42% | 0.03% |
| Feb. 15, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Restricted Stock Unit | 13332 | $0.00 | 13,332.0000 | 62,621,185 | 50.00% | 0.02% |
| Feb. 8, 2025 | Risser Eric Blasius | Chief Operating Officer | M | Common Stock | 11168 | $0.00 | 50,068.0000 | 62,621,185 | 28.71% | 0.02% |
| Feb. 8, 2025 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 11168 | $0.00 | 22,332.0000 | 62,621,185 | 33.34% | 0.02% |
| Feb. 7, 2025 | Bonvini Ezio | Sr VP, Research & CSO | A | Restricted Stock Unit | 21000 | $0.00 | 21,000.0000 | 62,621,185 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Bonvini Ezio | Sr VP, Research & CSO | A | Employee Stock Option (right to buy) | 128000 | $0.00 | 128,000.0000 | 62,621,185 | 9999.99% | 0.20% |
| Feb. 8, 2025 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 4311 | $2.60 | 107,749.0000 | 62,621,185 | 3.85% | 0.01% |
| Feb. 8, 2025 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 11168 | $0.00 | 112,060.0000 | 62,621,185 | 11.07% | 0.02% |
| Feb. 8, 2025 | Eck Stephen L. | Chief Medical Officer | M | Restricted Stock Unit | 11168 | $0.00 | 22,332.0000 | 62,621,185 | 33.34% | 0.02% |
| Feb. 7, 2025 | Eck Stephen L. | Chief Medical Officer | A | Restricted Stock Unit | 19000 | $0.00 | 19,000.0000 | 62,621,185 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Eck Stephen L. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 113000 | $0.00 | 113,000.0000 | 62,621,185 | 9999.99% | 0.18% |
| Feb. 8, 2025 | Eck Stephen L. | Chief Medical Officer | F | Common Stock | 3312 | $2.60 | 17,654.0000 | 62,621,185 | 15.80% | 0.01% |
| Feb. 8, 2025 | Eck Stephen L. | Chief Medical Officer | M | Common Stock | 11168 | $0.00 | 20,966.0000 | 62,621,185 | 113.98% | 0.02% |
| Feb. 8, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 9001 | $0.00 | 9,001.0000 | 62,621,185 | 9999.99% | 0.01% |
| Feb. 8, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | M | Restricted Stock Unit | 9001 | $0.00 | 17,999.0000 | 62,621,185 | 33.34% | 0.01% |
| Feb. 7, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | A | Restricted Stock Unit | 18000 | $0.00 | 18,000.0000 | 62,621,185 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 62,621,185 | 9999.99% | 0.17% |
| Feb. 8, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | F | Common Stock | 3727 | $2.60 | 13,590.0000 | 62,621,185 | 21.52% | 0.01% |
| Feb. 8, 2025 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 9001 | $0.00 | 17,317.0000 | 62,621,185 | 108.24% | 0.01% |
| Feb. 8, 2025 | Koenig Scott | President and CEO | M | Restricted Stock Unit | 31673 | $0.00 | 63,327.0000 | 62,621,185 | 33.34% | 0.05% |
| Feb. 8, 2025 | Koenig Scott | President and CEO | A | Common Stock | 31673 | $0.00 | 735,086.0000 | 62,621,185 | 4.50% | 0.05% |
| Feb. 8, 2025 | Smith Beth Ann | VP, Controller & Treasurer | M | Restricted Stock Unit | 1583 | $0.00 | 3,167.0000 | 62,621,185 | 33.33% | 0.00% |
| Feb. 7, 2025 | Smith Beth Ann | VP, Controller & Treasurer | A | Restricted Stock Unit | 7850 | $0.00 | 7,850.0000 | 62,621,185 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Smith Beth Ann | VP, Controller & Treasurer | A | Employee Stock Option (right to buy) | 47050 | $0.00 | 47,050.0000 | 62,621,185 | 9999.99% | 0.08% |
| Feb. 8, 2025 | Smith Beth Ann | VP, Controller & Treasurer | F | Common Stock | 612 | $2.60 | 8,860.0000 | 62,621,185 | 6.46% | 0.00% |
| Feb. 8, 2025 | Smith Beth Ann | VP, Controller & Treasurer | M | Common Stock | 1583 | $0.00 | 9,472.0000 | 62,621,185 | 20.07% | 0.00% |
| Feb. 8, 2025 | Karrels James | SVP, CFO and Secretary | M | Restricted Stock Unit | 10002 | $0.00 | 19,998.0000 | 62,621,185 | 33.34% | 0.02% |
| Feb. 7, 2025 | Karrels James | SVP, CFO and Secretary | A | Restricted Stock Unit | 19000 | $0.00 | 19,000.0000 | 62,621,185 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Karrels James | SVP, CFO and Secretary | A | Employee Stock Option (right to buy) | 113000 | $0.00 | 113,000.0000 | 62,621,185 | 9999.99% | 0.18% |
| Feb. 8, 2025 | Karrels James | SVP, CFO and Secretary | F | Common Stock | 3861 | $2.60 | 177,593.0000 | 62,621,185 | 2.13% | 0.01% |
| Feb. 8, 2025 | Karrels James | SVP, CFO and Secretary | M | Common Stock | 10002 | $0.00 | 181,454.0000 | 62,621,185 | 5.83% | 0.02% |
| Feb. 8, 2025 | Risser Eric Blasius | Chief Operating Officer | M | Restricted Stock Unit | 11168 | $0.00 | 22,332.0000 | 62,621,185 | 33.34% | 0.02% |
| Feb. 7, 2025 | Risser Eric Blasius | Chief Operating Officer | A | Restricted Stock Unit | 20000 | $0.00 | 20,000.0000 | 62,621,185 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Risser Eric Blasius | Chief Operating Officer | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 62,621,185 | 9999.99% | 0.19% |
| Feb. 8, 2025 | Risser Eric Blasius | Chief Operating Officer | F | Common Stock | 4311 | $2.60 | 45,757.0000 | 62,621,185 | 8.61% | 0.01% |
| Feb. 8, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Restricted Stock Unit | 9001 | $0.00 | 17,999.0000 | 62,621,185 | 33.34% | 0.01% |
| Feb. 7, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Restricted Stock Unit | 18000 | $0.00 | 18,000.0000 | 62,621,185 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 62,621,185 | 9999.99% | 0.17% |
| Feb. 8, 2025 | Peters Jeffrey Stuart | Senior VP and General Counsel | F | Common Stock | 3475 | $2.60 | 5,526.0000 | 62,621,185 | 38.61% | 0.01% |
| Oct. 7, 2024 | Koenig Scott | President and CEO | G | Common Stock | 53265 | $0.00 | 427,480.0000 | 62,865,841 | 14.23% | 0.08% |
| Oct. 7, 2024 | Koenig Scott | President and CEO | G | Common Stock | 53265 | $0.00 | 427,480.0000 | 62,865,841 | 11.08% | 0.08% |
| Sept. 23, 2024 | Koenig Scott | President and CEO | G | Common Stock | 374215 | $0.00 | 1,077,628.0000 | 61,929,198 | 53.20% | 0.60% |
| Sept. 23, 2024 | Koenig Scott | President and CEO | G | Common Stock | 374215 | $0.00 | 1,077,628.0000 | 61,929,198 | 25.78% | 0.60% |
| May 21, 2024 | Liu Margaret | Director | A | Employee Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Liu Margaret | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | SIEGEL JAY PHILIP | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | SIEGEL JAY PHILIP | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Chhabra Meenu | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 17077 | $3.66 | 33,577.0000 | 61,929,198 | 103.50% | 0.03% |
| May 21, 2024 | O'Brien Federica F. | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | O'Brien Federica F. | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Ferrante Karen Jean | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | Ferrante Karen Jean | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | STUMP DAVID C | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | STUMP DAVID C | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | HEIDEN WILLIAM K | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | HEIDEN WILLIAM K | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | HURWITZ EDWARD | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | HURWITZ EDWARD | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Jackson Scott Thomas | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | Jackson Scott Thomas | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Liu Margaret | Director | A | Employee Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 21, 2024 | Liu Margaret | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | Chhabra Meenu | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | STUMP DAVID C | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | O'Brien Federica F. | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | O'Brien Federica F. | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | Liu Margaret | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | Liu Margaret | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | Chhabra Meenu | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | Ferrante Karen Jean | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | HURWITZ EDWARD | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | HURWITZ EDWARD | Director | M | Common Stock | 4500 | $0.00 | 37,574.0000 | 61,929,198 | 13.61% | 0.01% |
| May 20, 2024 | Ferrante Karen Jean | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | SIEGEL JAY PHILIP | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | SIEGEL JAY PHILIP | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | HEIDEN WILLIAM K | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | HEIDEN WILLIAM K | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | Jackson Scott Thomas | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 20, 2024 | Jackson Scott Thomas | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | STUMP DAVID C | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Employee stock option (right to buy) | 42500 | $4.82 | 127,500.0000 | 61,929,198 | 25.00% | 0.07% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 3165 | $18.22 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 5351 | $17.74 | 3,165.0000 | 61,929,198 | 62.83% | 0.01% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 232 | $16.38 | 8,516.0000 | 61,929,198 | 2.65% | 0.00% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 147 | $15.51 | 8,748.0000 | 61,929,198 | 1.65% | 0.00% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 42500 | $15.07 | 8,895.0000 | 61,929,198 | 82.69% | 0.07% |
| April 4, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 42500 | $4.82 | 51,395.0000 | 61,929,198 | 477.80% | 0.07% |
| March 6, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Employee stock option (right to buy) | 10875 | $11.50 | 0.0000 | 61,929,198 | 100.00% | 0.02% |
| March 6, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 10875 | $11.50 | 19,770.0000 | 61,929,198 | 122.26% | 0.02% |
| March 6, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 8750 | $10.15 | 28,520.0000 | 61,929,198 | 44.26% | 0.01% |
| March 6, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 19625 | $21.50 | 8,895.0000 | 61,929,198 | 68.81% | 0.03% |
| March 6, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Employee stock option (right to buy) | 8750 | $10.15 | 39,375.0000 | 61,929,198 | 18.18% | 0.01% |
| March 4, 2024 | Risser Eric Blasius | Chief Operating Officer | S | Common Stock | 26159 | $19.63 | 38,900.0000 | 61,929,198 | 40.21% | 0.04% |
| March 4, 2024 | Risser Eric Blasius | Chief Operating Officer | M | Employee stock option (right to buy) | 15000 | $0.00 | 155,000.0000 | 61,929,198 | 8.82% | 0.02% |
| March 4, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 10000 | $11.50 | 18,316.0000 | 61,929,198 | 120.25% | 0.02% |
| March 4, 2024 | Karrels James | SVP, CFO and Secretary | S | Common Stock | 30000 | $20.50 | 171,452.0000 | 61,929,198 | 14.89% | 0.05% |
| March 4, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | M | Employee stock option (right to buy) | 10000 | $0.00 | 77,000.0000 | 61,929,198 | 11.49% | 0.02% |
| March 4, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | S | Common Stock | 10000 | $20.00 | 8,316.0000 | 61,929,198 | 54.60% | 0.02% |
| March 4, 2024 | Risser Eric Blasius | Chief Operating Officer | M | Common Stock | 15000 | $10.15 | 80,059.0000 | 61,929,198 | 23.06% | 0.02% |
| March 4, 2024 | Risser Eric Blasius | Chief Operating Officer | S | Common Stock | 15000 | $20.00 | 65,059.0000 | 61,929,198 | 18.74% | 0.02% |
| Feb. 26, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 16124 | $17.22 | 8,895.0000 | 61,929,198 | 64.45% | 0.03% |
| Feb. 22, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Restricted Stock Unit | 26250 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.04% |
| Feb. 22, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 26250 | $0.00 | 35,145.0000 | 61,929,198 | 295.11% | 0.04% |
| Feb. 22, 2024 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 28125 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.05% |
| Feb. 22, 2024 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 9366 | $17.11 | 100,892.0000 | 61,929,198 | 8.49% | 0.02% |
| Feb. 22, 2024 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 28125 | $0.00 | 110,258.0000 | 61,929,198 | 34.24% | 0.05% |
| Feb. 22, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | F | Common Stock | 10126 | $17.11 | 25,019.0000 | 61,929,198 | 28.81% | 0.02% |
| Feb. 15, 2024 | Risser Eric Blasius | Chief Operating Officer | M | Common Stock | 16670 | $0.00 | 70,938.0000 | 61,929,198 | 30.72% | 0.03% |
| Feb. 15, 2024 | Risser Eric Blasius | Chief Operating Officer | M | Restricted Stock Unit | 16670 | $0.00 | 33,330.0000 | 61,929,198 | 33.34% | 0.03% |
| Feb. 15, 2024 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 16670 | $0.00 | 33,330.0000 | 61,929,198 | 33.34% | 0.03% |
| Feb. 15, 2024 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 5871 | $17.40 | 82,133.0000 | 61,929,198 | 6.67% | 0.01% |
| Feb. 15, 2024 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 16670 | $0.00 | 88,004.0000 | 61,929,198 | 23.37% | 0.03% |
| Feb. 15, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | M | Restricted Stock Unit | 13336 | $0.00 | 26,664.0000 | 61,929,198 | 33.34% | 0.02% |
| Feb. 15, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | F | Common Stock | 5020 | $17.40 | 8,316.0000 | 61,929,198 | 37.64% | 0.01% |
| Feb. 15, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | M | Common Stock | 13336 | $0.00 | 13,336.0000 | 61,929,198 | 9999.99% | 0.02% |
| Feb. 15, 2024 | Karrels James | SVP, CFO and Secretary | M | Restricted Stock Unit | 15003 | $0.00 | 29,997.0000 | 61,929,198 | 33.34% | 0.02% |
| Feb. 15, 2024 | Karrels James | SVP, CFO and Secretary | F | Common Stock | 5327 | $17.40 | 201,452.0000 | 61,929,198 | 2.58% | 0.01% |
| Feb. 15, 2024 | Karrels James | SVP, CFO and Secretary | M | Common Stock | 15003 | $0.00 | 206,779.0000 | 61,929,198 | 7.82% | 0.02% |
| Feb. 15, 2024 | Eck Stephen L. | Chief Medical Officer | M | Common Stock | 16670 | $0.00 | 16,670.0000 | 61,929,198 | 9999.99% | 0.03% |
| Feb. 15, 2024 | Eck Stephen L. | Chief Medical Officer | F | Common Stock | 6872 | $17.40 | 9,798.0000 | 61,929,198 | 41.22% | 0.01% |
| Feb. 15, 2024 | Eck Stephen L. | Chief Medical Officer | M | Restricted Stock Unit | 16670 | $0.00 | 33,330.0000 | 61,929,198 | 33.34% | 0.03% |
| Feb. 15, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 13336 | $0.00 | 13,336.0000 | 61,929,198 | 9999.99% | 0.02% |
| Feb. 15, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | F | Common Stock | 4441 | $17.40 | 8,895.0000 | 61,929,198 | 33.30% | 0.01% |
| Feb. 15, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Restricted Stock Unit | 13336 | $0.00 | 26,664.0000 | 61,929,198 | 33.34% | 0.02% |
| Feb. 15, 2024 | Koenig Scott | President and CEO | M | Common Stock | 42341 | $0.00 | 1,091,977.0000 | 61,929,198 | 4.03% | 0.07% |
| Feb. 15, 2024 | Koenig Scott | President and CEO | F | Common Stock | 14349 | $17.40 | 1,077,628.0000 | 61,929,198 | 1.31% | 0.02% |
| Feb. 15, 2024 | Koenig Scott | President and CEO | M | Restricted Stock Unit | 42341 | $0.00 | 84,659.0000 | 61,929,198 | 33.34% | 0.07% |
| Feb. 15, 2024 | Cilinski Lynn | VP, Controller and Treasurer | M | Common Stock | 6668 | $0.00 | 8,591.0000 | 61,929,198 | 346.75% | 0.01% |
| Feb. 15, 2024 | Cilinski Lynn | VP, Controller and Treasurer | F | Common Stock | 2378 | $17.40 | 6,213.0000 | 61,929,198 | 27.68% | 0.00% |
| Feb. 15, 2024 | Cilinski Lynn | VP, Controller and Treasurer | M | Restricted Stock Unit | 6668 | $0.00 | 13,332.0000 | 61,929,198 | 33.34% | 0.01% |
| Feb. 15, 2024 | Risser Eric Blasius | Chief Operating Officer | F | Common Stock | 5879 | $17.40 | 65,059.0000 | 61,929,198 | 8.29% | 0.01% |
| Feb. 8, 2024 | Cilinski Lynn | VP, Controller and Treasurer | A | Restricted Stock Unit | 17000 | $0.00 | 17,000.0000 | 61,929,198 | 9999.99% | 0.03% |
| Feb. 8, 2024 | Risser Eric Blasius | Chief Operating Officer | A | Employee Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 61,929,198 | 9999.99% | 0.15% |
| Feb. 8, 2024 | Risser Eric Blasius | Chief Operating Officer | A | Restricted Stock Unit | 33500 | $0.00 | 33,500.0000 | 61,929,198 | 9999.99% | 0.05% |
| Feb. 8, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Employee Stock Option (right to buy) | 71000 | $0.00 | 71,000.0000 | 61,929,198 | 9999.99% | 0.11% |
| Feb. 8, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Restricted Stock Unit | 27000 | $0.00 | 27,000.0000 | 61,929,198 | 9999.99% | 0.04% |
| Feb. 8, 2024 | Koenig Scott | President and CEO | A | Employee Stock Option (right to buy) | 248000 | $0.00 | 248,000.0000 | 61,929,198 | 9999.99% | 0.40% |
| Feb. 8, 2024 | Koenig Scott | President and CEO | A | Restricted Stock Unit | 95000 | $0.00 | 95,000.0000 | 61,929,198 | 9999.99% | 0.15% |
| Feb. 8, 2024 | Karrels James | SVP, CFO and Secretary | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 61,929,198 | 9999.99% | 0.13% |
| Feb. 8, 2024 | Karrels James | SVP, CFO and Secretary | A | Restricted Stock Unit | 30000 | $0.00 | 30,000.0000 | 61,929,198 | 9999.99% | 0.05% |
| Feb. 8, 2024 | Eck Stephen L. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 61,929,198 | 9999.99% | 0.15% |
| Feb. 8, 2024 | Eck Stephen L. | Chief Medical Officer | A | Restricted Stock Unit | 33500 | $0.00 | 33,500.0000 | 61,929,198 | 9999.99% | 0.05% |
| Feb. 8, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | A | Employee Stock Option (right to buy) | 71000 | $0.00 | 71,000.0000 | 61,929,198 | 9999.99% | 0.11% |
| Feb. 8, 2024 | Bonvini Ezio | Sr VP, Research & CSO | A | Restricted Stock Unit | 33500 | $0.00 | 33,500.0000 | 61,929,198 | 9999.99% | 0.05% |
| Feb. 8, 2024 | Cilinski Lynn | VP, Controller and Treasurer | A | Employee Stock Option (right to buy) | 45000 | $18.30 | 45,000.0000 | 61,929,198 | 9999.99% | 0.07% |
| Feb. 8, 2024 | Spitznagel Thomas | Sr VP, Technical Ops | A | Restricted Stock Unit | 27000 | $0.00 | 27,000.0000 | 61,929,198 | 9999.99% | 0.04% |
| Feb. 8, 2024 | Bonvini Ezio | Sr VP, Research & CSO | A | Employee Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 61,929,198 | 9999.99% | 0.15% |
| Feb. 5, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Employee stock option (right to buy) | 21875 | $0.00 | 48,125.0000 | 61,929,198 | 31.25% | 0.04% |
| Feb. 7, 2024 | Bonvini Ezio | Sr VP, Research & CSO | S | Common Stock | 3334 | $18.00 | 71,334.0000 | 61,929,198 | 4.47% | 0.01% |
| Feb. 5, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 54376 | $11.50 | 54,376.0000 | 61,929,198 | 9999.99% | 0.09% |
| Feb. 5, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 21875 | $10.15 | 76,251.0000 | 61,929,198 | 40.23% | 0.04% |
| Feb. 5, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 54376 | $16.50 | 21,875.0000 | 61,929,198 | 71.31% | 0.09% |
| Feb. 5, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 21875 | $16.50 | 0.0000 | 61,929,198 | 100.00% | 0.04% |
| Feb. 5, 2024 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Employee stock option (right to buy) | 54376 | $0.00 | 10,875.0000 | 61,929,198 | 83.33% | 0.09% |
| Feb. 1, 2024 | Bonvini Ezio | Sr VP, Research & CSO | S | Common Stock | 13316 | $15.00 | 74,668.0000 | 61,929,198 | 15.13% | 0.02% |
| Jan. 19, 2024 | Bonvini Ezio | Sr VP, Research & CSO | S | Common Stock | 13316 | $12.00 | 87,984.0000 | 61,929,198 | 13.15% | 0.02% |
| Dec. 20, 2023 | Bonvini Ezio | Sr VP, Research & CSO | S | Common Stock | 18880 | $10.08 | 101,300.0000 | 61,433,124 | 15.71% | 0.03% |
| Oct. 2, 2023 | BIOTECH TARGET N V | TenPercentOwner | P | Common Stock | 150000 | $4.46 | 9,929,963.0000 | 61,433,124 | 1.53% | 0.24% |
| Sept. 7, 2023 | BIOTECH TARGET N V | TenPercentOwner | P | Common Stock | 200000 | $5.26 | 9,779,963.0000 | 61,433,124 | 2.09% | 0.33% |
| Aug. 30, 2023 | HURWITZ EDWARD | Director | P | Common Stock | 15000 | $4.91 | 33,074.0000 | 61,433,124 | 82.99% | 0.02% |
| May 31, 2023 | Liu Margaret | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | O'Brien Federica F. | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | O'Brien Federica F. | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 15759 | $0.00 | 15,759.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | Chhabra Meenu | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | SIEGEL JAY PHILIP | Director | A | Stock Option (right to buy) | 21490 | $0.00 | 21,490.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | SIEGEL JAY PHILIP | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | SIEGEL JAY PHILIP | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | HEIDEN WILLIAM K | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | HEIDEN WILLIAM K | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | STUMP DAVID C | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | STUMP DAVID C | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | Liu Margaret | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | Jackson Scott Thomas | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | Jackson Scott Thomas | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | HURWITZ EDWARD | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | HURWITZ EDWARD | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | Ferrante Karen Jean | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |
| May 31, 2023 | Ferrante Karen Jean | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| March 10, 2023 | Peters Jeffrey Stuart | Senior VP and General Counsel | S | Common Stock | 5372 | $6.03 | 0.0000 | 61,433,124 | 100.00% | 0.01% |
| Feb. 22, 2023 | Bonvini Ezio | Sr VP, Research & CSO | M | Restricted Stock Unit | 9375 | $0.00 | 0.0000 | 61,433,124 | 100.00% | 0.02% |
| Feb. 22, 2023 | Bonvini Ezio | Sr VP, Research & CSO | F | Common Stock | 3619 | $6.55 | 120,180.0000 | 61,433,124 | 2.92% | 0.01% |
| Feb. 22, 2023 | Bonvini Ezio | Sr VP, Research & CSO | M | Common Stock | 9375 | $0.00 | 123,799.0000 | 61,433,124 | 8.19% | 0.02% |
| Feb. 22, 2023 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Restricted Stock Unit | 8750 | $0.00 | 0.0000 | 61,433,124 | 100.00% | 0.01% |
| Feb. 22, 2023 | Peters Jeffrey Stuart | Senior VP and General Counsel | F | Common Stock | 3378 | $6.55 | 5,372.0000 | 61,433,124 | 38.61% | 0.01% |
| Feb. 22, 2023 | Peters Jeffrey Stuart | Senior VP and General Counsel | M | Common Stock | 8750 | $0.00 | 8,750.0000 | 61,433,124 | 9999.99% | 0.01% |
| Feb. 15, 2023 | Spitznagel Thomas | Sr VP, Technical Ops | A | Restricted Stock Unit | 40000 | $0.00 | 40,000.0000 | 61,433,124 | 9999.99% | 0.07% |
| Feb. 15, 2023 | Spitznagel Thomas | Sr VP, Technical Ops | A | Employee stock option (right to buy) | 170000 | $0.00 | 170,000.0000 | 61,433,124 | 9999.99% | 0.28% |
| Feb. 15, 2023 | Koenig Scott | President and CEO | A | Restricted Stock Unit | 127000 | $0.00 | 127,000.0000 | 61,433,124 | 9999.99% | 0.21% |
| Feb. 15, 2023 | Koenig Scott | President and CEO | A | Employee stock option (right to buy) | 510000 | $0.00 | 510,000.0000 | 61,433,124 | 9999.99% | 0.83% |
| Feb. 15, 2023 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Restricted Stock Unit | 40000 | $0.00 | 40,000.0000 | 61,433,124 | 9999.99% | 0.07% |
| Feb. 15, 2023 | Risser Eric Blasius | Chief Operating Officer | A | Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 61,433,124 | 9999.99% | 0.08% |
| Feb. 15, 2023 | Cilinski Lynn | VP, Controller and Treasurer | A | Employee stock option (right to buy) | 75000 | $0.00 | 75,000.0000 | 61,433,124 | 9999.99% | 0.12% |
| Feb. 15, 2023 | Cilinski Lynn | VP, Controller and Treasurer | A | Restricted Stock Unit | 20000 | $0.00 | 20,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| Feb. 15, 2023 | Karrels James | SVP, CFO and Secretary | A | Employee stock option (right to buy) | 180000 | $0.00 | 180,000.0000 | 61,433,124 | 9999.99% | 0.29% |
| Feb. 15, 2023 | Karrels James | SVP, CFO and Secretary | A | Restricted Stock Unit | 45000 | $0.00 | 45,000.0000 | 61,433,124 | 9999.99% | 0.07% |
| Feb. 15, 2023 | Eck Stephen L. | Chief Medical Officer | A | Employee stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 61,433,124 | 9999.99% | 0.33% |
| Feb. 15, 2023 | Bonvini Ezio | Sr VP, Research & CSO | A | Employee stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 61,433,124 | 9999.99% | 0.33% |
| Feb. 15, 2023 | Bonvini Ezio | Sr VP, Research & CSO | A | Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 61,433,124 | 9999.99% | 0.08% |
| Feb. 15, 2023 | Peters Jeffrey Stuart | Senior VP and General Counsel | A | Employee stock option (right to buy) | 170000 | $0.00 | 170,000.0000 | 61,433,124 | 9999.99% | 0.28% |
| Feb. 15, 2023 | Risser Eric Blasius | Chief Operating Officer | A | Employee stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 61,433,124 | 9999.99% | 0.33% |
| Feb. 15, 2023 | Eck Stephen L. | Chief Medical Officer | A | Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 61,433,124 | 9999.99% | 0.08% |
| Feb. 14, 2023 | BIOTECH TARGET N V | TenPercentOwner | P | Common Stock | 500000 | $5.07 | 9,579,963.0000 | 61,433,124 | 5.51% | 0.81% |
| Jan. 19, 2023 | BIOTECH TARGET N V | TenPercentOwner | P | Common Stock | 150000 | $5.30 | 9,079,963.0000 | 61,433,124 | 1.68% | 0.24% |
| Jan. 3, 2023 | Chhabra Meenu | Director | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 61,433,124 | 9999.99% | 0.06% |
| Jan. 3, 2023 | Liu Margaret | Director | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 61,433,124 | 9999.99% | 0.06% |